FDA issued a Warning Letter to Jubilant Generics Limited on 3/6/2019 for a later inspection.
483 Jubilant Generics Mar 2013

483 Jubilant Generics Mar 2013

$119 - Not in Stock

FDA investigators audited the Jubilant Generics - Sikanderpur Bhainswal, India facility and issued inspectional observations (via FDA 483) on 01 Mar 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Mar 2013
  • Location: Sikanderpur Bhainswal, India
  • FEI: 3006895982

Pre-Order Not Available